Gilad Yavetz - 13 May 2026 Form 4 Insider Report for Enlight Renewable Energy Ltd. (ENLT)

Reporting relationship: EXEC. CHAIRMAN OF THE BOARD, Director
Issuer ticker: ENLT
Reported as of: 13 May 2026
Net transaction value: -$9,178,000
SEC form: 4
Accepted by SEC: 14 May 2026, 07:33:35 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Helit Megido as attorney-in-fact for Gilad Yavetz

Key filing fact

Gilad Yavetz filed Form 4 for Enlight Renewable Energy Ltd. (ENLT) on 14 May 2026.

Key facts

This page summarizes Gilad Yavetz's Form 4 filing for Enlight Renewable Energy Ltd. (ENLT).
5 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 14 May 2026, 07:33.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: -$9,178,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002108306 Primary reporting owner

Yavetz Gilad

Relationship: EXEC. CHAIRMAN OF THE BOARD, Director
Address: C/O ENLIGHT RENEWABLE ENERGY LTD., 13 AMAL ST. AFEK INDUSTRIAL PARK, ROSH HAAYIN, ISRAEL
Signature: /s/ Helit Megido as attorney-in-fact for Gilad Yavetz
Signature date: 14 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ENLT transaction

Ordinary shares, NIS 0.1 par value per share

Options Exercise

Transaction value
Shares: +77,210
Change %: +8.7%
Price: $23.22^*
Shares after: 967,157
Date: 13 May 2026
Ownership: Direct
Footnotes: F1, F2

ENLT transaction

Ordinary shares, NIS 0.1 par value per share

Tax liability

Transaction value
Shares: -20,721
Change %: -2.1%
Price: $91.78^*
Shares after: 946,436
Date: 13 May 2026
Ownership: Direct
Footnotes: F2, F3, F4

ENLT transaction

Ordinary shares, NIS 0.1 par value per share

Sale

Transaction value: $5,184,560
Shares: -56,489
Change %: -6%
Price: $91.78
Shares after: 889,947
Date: 13 May 2026
Ownership: Direct
Footnotes: F2, F4

ENLT transaction

Ordinary shares, NIS 0.1 par value per share

Sale

Transaction value: $3,993,440
Shares: -43,511
Change %: -4.9%
Price: $91.78
Shares after: 846,436
Date: 13 May 2026
Ownership: Direct
Footnotes: F2, F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ENLT transaction Derivative

Stock Options (right to buy)

Options Exercise

Transaction value
Shares: -77,210
Change %: -22%
Price: $0.000000^*
Shares after: 274,997
Date: 13 May 2026
Ownership: Direct
Underlying class: Ordinary shares, NIS 0.1 par value per share
Underlying amount: 77,210
Exercise price: $23.22
Footnotes: F1, F5

ENLT holding Derivative

Stock Options (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 345,927
Date: 13 May 2026
Ownership: Direct
Underlying class: Ordinary shares, NIS 0.1 par value per share
Underlying amount: 345,927
Exercise price: $27.33
Footnotes: F6, F7, F8

ENLT holding Derivative

Performance-Based RSUs

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 76,055
Date: 13 May 2026
Ownership: Direct
Underlying class: Ordinary shares, NIS 0.1 par value per share
Underlying amount: 76,055
Exercise price
Footnotes: F8, F9

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 9 footnotes

Footnote F1

Represents an exercise price of NIS 71.89, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Footnote F2

Includes (i) 43,512 restricted share units granted on April 17, 2024, with 21,756 vesting on each of April 17, 2027 and April 17, 2028; and (ii) 6,726 restricted share units granted on October 1, 2025, with 1,681 vesting on October 1, 2026, 1,682 vesting on October 1, 2027, 1,681 vesting on October 1, 2028, and 1,682 vesting on October 1, 2029. Each restricted share unit represents a contingent right to receive one ordinary share of the Company.

Footnote F3

These shares were retained by the Company in payment of the exercise price of the employee stock options exercised by the Reporting Person. The amount retained by the Company was not in excess of the amount of the exercise price.

Footnote F4

Represents a transaction price of NIS 267.00, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 2.909 as of the date immediately preceding the date of the transaction.

Footnote F5

Stock options were granted on September 30, 2021, with 24,997 having vested on September 30, 2023, 50,000 having vested on December 30, 2023, 50,000 having vested on March 30, 2023, 50,000 having vested on June 30, 2023, 50,000 having vested on September 30, 2024, 12,500 having vested on December 30, 2024, 12,500 having vested on March 30, 2025, 12,500 having vested on June 30, 2025, and 12,500 having vested on September 30, 2025.

Footnote F6

Represents an exercise price of NIS 84.60, converted to U.S. dollars using the Bank of Israel representative exchange rate of $1.00 to NIS 3.096 as of March 18, 2026.

Footnote F7

Stock options were granted on October 1, 2025, with 86,481 vesting on October 1, 2026, and 86,482 vesting on each of October 1, 2027, October 1, 2028, and October 1, 2029.

Footnote F8

No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.

Footnote F9

Performance-based RSUs ("PSUs") were granted on October 1, 2025 and vest in four annual tranches: 19,013 on October 1, 2026, and 19,014 on each of October 1, 2027, 2028, and 2029, beginning 12 months after the grant date, subject to continued service as an office holder and achievement of performance metrics for the preceding calendar year. The metrics, Total Income and Revenues, and Adjusted EBITDA (each as reported in the Company's Annual Report on Form 20-F), are measured against the midpoint of the Company's forecast published at the start of the applicable performance year. Achievement of 90% of the target yields 50% vesting for that metric's portion of the tranche, with linear interpolation for achievement between 90% and 100%. Metrics are weighted equally and evaluated independently; overperformance in one cannot offset the other. Each PSU represents a contingent right to receive one ordinary share of the Company upon vesting.